Nicotinamide Riboside Shows Promise in Treating Werner Syndrome
TL;DR Summary
A groundbreaking clinical trial demonstrated that nicotinamide riboside (NR), a supplement that boosts NAD+ levels, significantly improved health markers in Werner syndrome patients, including skin ulcers, arterial stiffness, and kidney function, offering new hope for this rare aging disorder and insights into aging processes.
- Common supplement reverses premature aging in landmark human trial ScienceDaily
- Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder Business Wire
- Nicotinamide riboside shows promise in treating Werner syndrome symptoms News-Medical
- Niagen study shows promise for Werner Syndrome treatment By Investing.com Investing.com India
- Trial into rare genetic disease Werner syndrome reports promising results Pharmafile
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
94%
695 → 44 words
Want the full story? Read the original article
Read on ScienceDaily